· JAMA 2020 · clinical practice guideline · n=?

Primary Care Interventions for Prevention and Cessation of Tobacco Use in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.

Cited 99 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Clinical practice guideline and expert recommendation statement

PubMed 32343336 · doi:10.1001/jama.2020.4679 · record verified 2026-08-29

What was done

The US Preventive Services Task Force (USPSTF) updated its 2013 recommendation regarding primary care interventions for tobacco prevention and cessation in school-aged children and adolescents younger than 18 years. The task force commissioned a systematic review of the benefits and harms of primary care-feasible interventions, including electronic cigarettes alongside conventional tobacco products.

What was found

No numerical outcome estimates or sample sizes are reported in the abstract. The USPSTF determined with moderate certainty that primary care-feasible behavioral interventions (such as brief counseling or education) provide a moderate net benefit in preventing tobacco use initiation (B recommendation). For tobacco cessation among youth who already smoke, evidence was found insufficient to assess the balance of benefits and harms due to a lack of adequately powered behavioral counseling trials and a lack of medication studies (I statement).

Why it matters

This guideline supports routine behavioral counseling by primary care clinicians to prevent tobacco and e-cigarette initiation in children and adolescents, while underscoring a major evidence deficit for youth cessation interventions.

Limits

The abstract provides no quantitative data or study counts. Available cessation evidence is limited by underpowered behavioral studies and an absence of pediatric pharmacotherapy trials.

Cited by